Atea Pharmaceuticals, Inc. (AVIR) Shareholders’ equity 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) shareholders’ equity at each fiscal year-end, per SEC filings.
$710.1MFY2022 · since FY2021: $547.8M → $710.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $710.1M | +29.6% |
| FY2021 | $547.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice